Potrero Capital Research’s Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant CPUH.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-37,500
Closed -$18K 65
2022
Q1
$18K Buy
+37,500
New +$371K 0.01% 53

Other funds holding CPUH.U

Potrero Capital Research's CPUH.U Position: Q2 2022 in Review

Potrero Capital Research sold out of Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant (CPUH.U) in Q2 2022, closing a stake of 37,500 shares — an estimated $18K sold.

Potrero Capital Research first reported a position in CPUH.U in Q1 2022 and held it in 1 quarter. The position peaked at $18K in Q1 2022. 38 funds tracked by Wall St. Rank hold CPUH.U as of Q2 2022.

  • Potrero Capital Research reported no remaining Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position as of Q2 2022 after selling out during the quarter.
  • Potrero Capital Research sold 37,500 Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant shares in Q2 2022, an estimated $18K.
  • Potrero Capital Research first reported a position in Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant in Q1 2022 and held it in 1 quarter.
  • Potrero Capital Research's Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position peaked at $18K in Q1 2022.
  • 38 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant as of Q2 2022.

Based on Potrero Capital Research's 13F filing for Q2 2022, filed 15 Aug 2022.